About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNANCT05883111

HPV Self-testing in Transgender Individuals

Human papillomavirus (HPV) is a common virus that spreads through skin-to-skin contact. Some HPV types can cause changes in cells that lead to cancer and are known as 'high-risk' HPV (hrHPV). hrHPV is...

Lead sponsor: Queen Mary University of London•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Queen Mary University of London

Collaborators

National Cancer Institute (NCI)

Age

21 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Identify as transgender or non-binary
•Be between 25 - 65 years of age
•Be registered with a general practitioner
•Have an intact cervix
•Have used testosterone therapy within the last year
•Be willing, and able to understand and consent to study procedures
•Identify as transgender or non-binary
•Be 18 years of age or older
•Have undergone vaginoplasty by any method at least 1 year ago
•Be willing, and able to understand and consent to study procedures

Exclusion Criteria

•Have a variation of sex characteristics (also known as a disorder of sex development)
•Have an allergy to any of the ingredients in the oral rinse (Scope)
•Be diagnosed with, or under investigation for, an inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease). This does not include irritable bowel syndrome - participants with this are eligible to enroll.
•Be a member of a vulnerable population, which includes pregnant people, fetuses, children, prisoners, or anyone unable to independently offer consent.

Related studies

RECRUITINGPhase 4

Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection

NCT07493824 · Persistent HR-HPV Infection of the Cervix

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330 · Cervix Cancer, HIV Infections, and more

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

NCT07225530 · HIV Infections, HPV Infection, and more

Pocket Colposcopy Using CARE Algorithm

NCT06458062 · Cervical Cancer, HPV Infection

RECRUITINGPhase 2

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

NCT06756269 · HPV Infection, HPV-Related Carcinoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 19, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment100

Start dateFeb 2024

Last updatedFeb 19, 2026

Condition

Locations shown

University Hospitals Sussex NHS Foundation Trust Sexual Health Service

Brighton

Ambrose King Centre, Barts Health NHS Trust

London

CliniQ, Caldicott Centre, Kings College Hospitals

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 19, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions